Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-blockade in heart failure. Basic concepts and clinical results

M Packer1

  • 1Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, New York, USA.

American Journal of Hypertension
|March 21, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bespoke magnetic field design for a magnetically shielded cold atom interferometer.

Scientific reports·2022
Same author

Acute, non-COVID related medical admissions during the first wave of COVID-19: A retrospective comparison of changing patterns of disease.

Acute medicine·2020
Same author

[What will cataract surgery look like in the future? Alternatives in the pipeline].

Journal francais d'ophtalmologie·2020
Same author

Object surveillance with radio-frequency atomic magnetometers.

The Review of scientific instruments·2020
Same author

Contrasting effects on the risk of macrovascular and microvascular events of antihyperglycemic drugs that enhance sodium excretion and lower blood pressure.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Dental education: Potentially damaging disconnect.

British dental journal·2017

Beta-blockers significantly improve outcomes for patients with chronic heart failure by blocking the detrimental effects of the sympathetic nervous system. These medications reduce mortality and hospitalizations, enhancing quality of life.

Area of Science:

  • Cardiology
  • Pharmacology
  • Physiology

Background:

  • Sympathetic nervous system activation negatively impacts chronic heart failure.
  • Norepinephrine exposure causes adverse physiological and molecular changes in heart failure.
  • Understanding these mechanisms explains the benefits of beta-blockers.

Purpose of the Study:

  • To review the role of sympathetic nervous system activation in heart failure.
  • To highlight the benefits of beta-blocker therapy in managing heart failure.
  • To discuss the clinical evidence supporting beta-blocker use in left ventricular systolic dysfunction.

Main Methods:

  • Review of experimental and clinical studies on sympathetic nervous system in heart failure.
  • Analysis of data on the effects of norepinephrine and beta-blockers.

Related Experiment Videos

  • Synthesis of findings from clinical trials investigating beta-blocker efficacy.

    • Main Results:

    • Beta-blockers counteract the adverse effects of norepinephrine, retarding cardiac remodeling.
    • Beta-blockers reduce mortality post-myocardial infarction, especially in heart failure patients.
    • Carvedilol demonstrated a 65% reduction in all-cause mortality in cardiomyopathy patients.

    Conclusions:

    • Pharmacologic blockade of the sympathetic nervous system offers significant clinical benefits.
    • Beta-blocker therapy is crucial for improving survival and reducing hospitalizations in heart failure.
    • These findings support the use of beta-blockers in patients with left ventricular systolic dysfunction.